NCT05262127 (Flash-EMDR) is a NA clinical trial of Flash Version of EMDR in PTSD, sponsored by York University.

Who is sponsoring NCT05262127?

NCT05262127 is sponsored by York University.

What drugs are being tested in NCT05262127?

Interventions in NCT05262127: Flash Version of EMDR.

Is NCT05262127 still recruiting?

NCT05262127 is currently status unknown. Last updated 4 January 2023.

Last reviewed 2023-01-04 · How we verify

NCT05262127: Flash-EMDR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Assessment of the Flash - Eye Movement Desensitization and Reprocessing

Status unknown NA Last updated 4 January 2023

What this trial tests

NA trial testing Flash Version of EMDR in PTSD in 90 participants. Status unknown.

Timeline

1 September 2021

Primary endpoint
1 March 2023

1 March 2023

Quick facts

Lead sponsor	York University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	90
Start date	1 September 2021
Primary completion	1 March 2023
Estimated completion	1 March 2023
Sites	2 locations across Canada

Drugs / interventions tested

Flash Version of EMDR

Conditions studied

PTSD — all drugs for PTSD →

Sponsor

York University

Who can join

Adults 20 to 60, any sex, with PTSD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess the Flash version of EMDR in reductions of the disturbance of upsetting memories at post-intervention, and 1-month follow up within a double-blinded, online 2-arm randomized controlled trial (RCT) with self-report outcomes. We will assess 45 per group, adequate for the detection of a medium effect size. This double-blinded, RCT will assess the comparative efficacy of these two online interventions designed to reduce memory disturbance.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Clinical Assessment of Eye Movement Desensitization and Reprocessing in Memory Distress: Protocol for a Double-Blinded Randomized Controlled Trial.
Babaei N, Kerry C, Goode K, Dang K, et al · · 2023 · cited 1× · PMID 37171869 · DOI 10.2196/38552

Verify or expand the search:

Other recruiting trials for PTSD

Currently open trials in the same condition.

NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting

Other York University trials

Trials by the same sponsor.

NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
NCT07312409 — Does Taurine Supplementation Improve Vascular Function and Orthostatic Responses in Long COVID? · NA · not yet recruiting
NCT07418320 — Grow Together, Thrive Together: A Feasibility Study of a Brief Relationship Intervention for Emerging Adults and Their C · NA · not yet recruiting
NCT07351630 — Building Blocks for Child and Family Well-being · NA · recruiting
NCT06458933 — Testing Interventions for Borderline Personality Disorder. · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05262127 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by York University
Last refreshed: 4 January 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05262127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing